In this episode, Kristin Gusack is joined by Dr. Florence-Damilola Odufalu, an Advanced Inflammatory Bowel Disease Fellow in the Division of Gastroenterology and Hepatology at The University of California, San Francisco. Together, they explore the intersection of Inflammatory Bowel Disease, Telehealth and Health Equity and cover some social determinants that we may see more commonly in the telemedicine setting.
This podcast (episode) covers the intersection of Inflammatory Bowel Disease, telehealth and health equity to help the healthcare team anticipate and overcome common social determinants that may be barriers to optimal care during telehealth visits.
Florence-Damilola Odufalu, MD
Advanced Inflammatory Bowel Disease Fellow
Department of Medicine
Division of Gastroenterology and Hematology
The University of California
San Francisco, California
Kristin M. Gusack, RD, CHCP
Medical Learning Institute, Inc.
Tarpon Springs, FL
This accredited CE activity is intended for primary care physicians, nurses, and advanced practice providers engaged in the care of patients with inflammatory bowel disease (IBD).
After completing accredited CE activity, the participant should be better able to:
|•||Summarize how socioeconomic factors impact care for patients with inflammatory bowel disease, especially during the COVID-19 pandemic.|
|•||Discuss skills or strategies the healthcare team can implement to overcome healthcare disparities further exacerbated by the pandemic|
Accreditation, Credit, and Support
This episode is accredited by Medical Learning Institute, Inc.
Physician Continuing Medical Education
Medical Learning Institute, Inc., is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Medical Learning Institute, Inc., designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Professional Development
Medical Learning Institute, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
Successful completion of this nursing continuing professional development activity will be awarded 0.5 contact hours.
There is no commercial support for this episode.
Disclosure & Conflict of Interest Policy
Medical Learning Institute, Inc., is committed to providing high quality accredited continuing education to healthcare professionals, as individuals and teams, with a protected space to learn, teach, and engage in scientific discourse free from influence from ineligible companies that may have an incentive to insert commercial bias into education. To that end, MLI requires faculty, presenters, planners, staff, and other individuals who are in a position to control the content of this accredited CE activity to disclose all financial relationships they have had in the past 24 months with ineligible companies as defined by the ACCME, as related to the content of this accredited CE activity, regardless of the amount or their view of the relevance to the accredited education. All identified COI will be thoroughly vetted and mitigated according to MLI policy. These disclosures will be provided to learners prior to the start of the accredited CE activity.
Florence-Damilola Odufalu, MD, has no relevant financial relationship(s) with ineligible companies to disclose for this educational activity.
Kristin M. Gusack, RD, CHCP, has no relevant financial relationship(s) with ineligible companies to disclose for this educational activity.
Planning Committee and Content/Peer Reviewers
The planners and content/peer reviewers from Medical Learning Institute, Inc., the accredited provider, do not have any relevant financial relationship(s) to disclose with ineligible companies unless listed below.
Disclosure of Unlabeled Use
This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this accredited CE activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the accredited CE activity are those of the presenters and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this accredited CE activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this accredited CE activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Method of Participation
There are no fees for participating in or receiving credit for this accredited activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.
In order to receive credit, learners must participate in the entire accredited CE activity and complete the post-test and evaluation form. A score of 70% or higher is needed to obtain credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form. If you have questions regarding the receipt of your emailed certificate, please contact via email at firstname.lastname@example.org.
Medical Learning Institute, Inc. is responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this accredited CE activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions.
The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of Medical Learning Institute, Inc. or any of its partners, providers, and/or supporters.
Accredited CE Activity Release Date: June 17, 2021
Accredited CE Activity Expiration Date: June 16, 2022
Time to complete activity: 30 minutes
Listen in to the episode!
Opt-in to the email notification list.
Once you have listened to the episode, click on the button below to be directed to the evaluation and application for credit. Once you have successfully completed the evaluation/posttest, your certificate will be emailed to you. Please allow up to 5 business days to receive your certificate.